An Epidemiology Model for Estimating the Numbers of US Patients With Multiple Myeloma by Line of Therapy and Treatment Exposure

The objective of this study was to estimate the number of patients with MM by LOT and the number of patients who have received at least 4 previous LOTs including proteasome inhibitors, immunomodulatory agents, and anti-CD38 monoclonal antibodies (mAbs).

Source: Value in Health - August 11, 2022 Category: International Medicine & Public Health Authors: Andreas Nikolaou, Cosmina Hogea, Yevgeniy Samyshkin, Eric M. Maiese, Leah Sansbury, Mustafa Oguz, Javier Cid-Ruzafa, Ritika Kapoor, Feng Wang Tags: Methodology Source Type: research